Theravance Biopharma, Inc.
$17.03
Market Cap
$884.70M
Shares Outstanding
51.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 16, 2014
Round Lot
100
Locale
US
Day Open
$17.04
Day High
$17.04
Day Low
$17.02
Volume
461.7K
VWAP
$17.03
Prev Close
$17.04
Transactions
--
Acc. Volume
--
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Theravance Biopharma, Inc. (TBPH) closed the 2026-09-16 session at $17.03, down 0.06% versus the previous close (-0.01). The stock opened at $17.04 and traded between $17.02 and $17.04 during that session. Session trading volume was 462K shares. The volume-weighted average price (VWAP) is $17.03.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Theravance Biopharma, Inc. has a market capitalization of $884.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. TBPH is listed on the XNAS exchange. The company employs approximately 90 people. Theravance Biopharma, Inc. is headquartered in GEORGE TOWN, GRAND CAYMAN, CA. The recorded listing date is 2014-05-16.
On this page you can find market TBPH stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.